Intolerance to an extensively hydrolysed formula mistaken for postoperative diarrhoea in a child with neuroblastoma

E Ward1, S Picton

  • 1Dietetic Department, St James's University Hospital, Leeds, UK.

Insights

Persistent diarrhea after neuroblastoma surgery can be a rare intolerance to extensively hydrolyzed protein formula, not just a postoperative issue. Early identification is key for managing pediatric feeding challenges.

Area of Science:

  • Pediatric Oncology
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Persistent diarrhea is a recognized complication after surgical resection for advanced abdominal neuroblastoma.
  • Pediatric patients with neuroblastoma often require nutritional support during treatment.

Observation:

  • A 10-month-old infant with stage IV neuroblastoma developed severe diarrhea post-surgery, initially attributed to the operation.
  • The infant was placed on continuous nasogastric feeding with an extensively hydrolyzed, non-milk protein formula.
  • Persistent diarrhea and subsequent rectal prolapse led to a diagnosis of allergic proctocolitis via colonoscopy and biopsy.

Findings:

  • The infant's severe diarrhea resolved rapidly upon discontinuation of the hydrolyzed protein formula.
  • This suggests a rare intolerance to the specific extensively hydrolyzed protein formula used for nutritional support.

Implications:

  • Clinicians should consider rare food intolerances, particularly to specialized formulas, when managing persistent diarrhea in post-surgical neuroblastoma patients.
  • Differentiating between surgical complications and iatrogenic conditions like allergic proctocolitis is crucial for appropriate patient management and nutritional support.
  • Further investigation into the specific triggers of allergic proctocolitis in infants receiving specialized nutrition is warranted.
Abstract

Related Concept Videos

Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...